Mark Throsby

Company: Gadeta

Job title: COO, CSO


Harnessing Natural gd T-cell Receptors (gd TCR) to Develop Effective Cellular Therapies for Solid Tumors 11:45 am

• Understanding the unique cancer targeting properties of γδ TCRs • Advantages of using engineered αβT cells engineered to express a defined tumor-reactive natural γδ TCR (TEG) • Broadly applicability of γδ TCRs for building allogeneic T cell platforms that retain native recognition and signaling propertiesRead more

day: Day 2 - Track A - Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.